ReviewInternational urology and nephrology2011
The epidemiology of end-stage renal disease in Nigeria: the way forward.
Review in International urology and nephrology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 52 citations in OpenAlex.
- Article
- CHALLENGES OF RENAL REPLACEMENT THERAPY IN NIGERIA: SOLUTIONS FROM MEDICAL STUDENTS' PERSPECTIVES.Annals of Ibadan postgraduate medicine · 2023Article
- Challenges to the right to health in sub-Saharan Africa: reflections on inequities in access to dialysis for patients with end-stage kidney failure.International journal for equity in health · 2022Review
- Otorhinolaryngologic, head and neck presentations among patients with chronic renal disease in a developing country.Journal of family medicine and primary care · 2020Article
- Prevalence, risk-inducing lifestyle, and perceived susceptibility to kidney diseases by gender among Nigerians residents in South Western Nigeria.African health sciences · 2020Article
- Traditional Medications Mixed with Ethylene Glycol in a Nigerian Patient on Hemodialysis.Cureus · 2020Article
- Nephroprotective effect ofInternational journal of physiology, pathophysiology and pharmacology · 2019Article
- Outcomes of tunneled internal jugular venous catheters for chronic haemodialysis at the University College Hospital, Ibadan, Nigeria.The Pan African medical journal · 2018Article
- Prevalence of risk factors for chronic kidney disease among adults in a university community in southern Nigeria.The Pan African medical journal · 2015Article
- Is the art of renal biopsy on the decline in Nigeria?Annals of Ibadan postgraduate medicine · 2014Article
- The management of chronic kidney disease and end-stage renal disease in Nigeria.International urology and nephrology · 2012Article
- Outcomes of Native Arteriovenous Fistula Creation for Haemodialysis in South-West Nigeria: A 5-Year Review from the Cardiovascular and Thoracic Surgery Unit of a Tertiary Institution.Journal of the West African College of SurgeonsArticle
Corrections and comments
- Commented on by
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The incidence of CKD (Chronic kidney disease) in Nigeria has been shown by various studies to range between 1.6 and 12.4%. We have shown that the burden of renal disease in Nigeria is probably significantly higher than any previous study on end-stage renal disease (ESRD) has documented, as most studies are hospital-based and fail to include the many patients who do not have access to hospital care. The increased prevalence of ESRD among blacks in the United States and South Africa compared with other races also suggests that ESRD may be more prevalent in Africa than in the United States and other developed nations. Common causes of CKD in Nigerian adults are glomerulonephritis and hypertension, while common causes in children are glomerulonephritis and posterior urethral valves. In the United States, diabetes and hypertension are the commonest causes of CKD and glomerulonephritis plays a less important role. Access to renal replacement therapy (RRT) in Nigeria is limited, and mortality rates are very high, ranging between 40 and 50%. Important steps towards improving the situation are the development of prevention programmes and increased funding to ensure increased availability of RRT. To achieve this, health policies concerning CKD must be formulated, and the lack of a renal registry makes it difficult for this to be done. There is need for the development of a functional organizational structure for the reporting of CKD in Nigeria, the Nigerian Renal Registry.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.